-
The Impact of Out-of-Pocket Costs on Adherence Amongst US Oncology Patients on Oral Anticancer Medications
Mar 10, 2025, 14:00 PM -
Costs and Complications of Hospitalization among Survivors of S. aureusbacteremia in the US: A Multicenter Retrospective Cohort Study, 2020-2022
Mar 10, 2025, 14:00 PM -
Building an ROI Tool for Diabetes Prevention Programs in the Kingdom of Saudi Arabia
Mar 10, 2025, 14:00 PM -
Economic and Social Impact of Protection Against Light Exposure During In Vitro Fertilization (IVF) in Hungary
Mar 10, 2025, 14:00 PM -
Economic Systematic Literature of Nirmatrelvir+Ritonavir for the Treatment of Patients With Mild to Moderate COVID-19
Mar 10, 2025, 14:00 PM -
Epidemiology, Demography and Comorbidities of Patients With Osteoporosis at Very High Risk of Fracture in China
Mar 10, 2025, 14:00 PM -
Unravelling the Diagnostic Delays and Disease Burden Associated with Endometriosis - A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Strategic Implications of EU HTAR (JCA and JSC) for Global Biopharma and Biotechs: Navigating Evolving Paradigms in Market Access
Mar 10, 2025, 14:00 PM -
Global, Regional, and National Burdens of Type 1 and Type 2 Diabetes Mellitus in Adolescents from 1990 to 2021, with Forecasts to 2030: A Systematic Analysis of the Global Burden of Disease Study 2021
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization Associated With Myotonic Dystrophy Type 1 With Complex Care Needs: Results From the Real-World IMPaCT Study
Mar 10, 2025, 14:00 PM -
Examining Factors Contributing to Age of Late-Onset Autoimmune Disease in U.S. Adults Using Hierarchical Clustering Mechanisms
Mar 10, 2025, 14:00 PM -
Psychometric Evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) Instrument in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)
Mar 10, 2025, 14:00 PM -
Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/ Refractory Neuroblastoma – Matching-Adjusted Indirect Treatment Comparison and Economic Evaluation in the Private Health Insurance System in Brazil
Mar 10, 2025, 14:00 PM -
Real-world Infusion and Post-Infusion Health Care Resource Use (HCRU) and Costs for CAR T Cell Treatment in Large B-Cell Lymphoma (LBCL): a Comparative Study of Liso-cel Versus Axi-cel
Mar 10, 2025, 14:00 PM -
Evaluating the Association Between Medicare Star Ratings Part D Medication Adherence Measures and the Part C Plan All-Cause Readmission Outcome Measure
Mar 10, 2025, 14:00 PM -
A Reanalysis of Canada's Drug Agency (CDA) Reports: Do Conclusions from Cost-Effectiveness Analyses Using Quality-Adjusted Life-Years (QALYs) Hold When Evaluating with Equal Value of Life-Years Gained (evLYG)?
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Sotagliflozin for Patients With Type 1 Diabetes and Chronic Kidney Disease, With and Without Dynamic Pricing
Mar 10, 2025, 14:00 PM -
Economic Burden of Prader-Willi Syndrome Among Pediatric Patients in the United States
Mar 10, 2025, 14:00 PM -
The Reimbursement Status of Ustekinumab Across HTAs: A Global Perspective
Mar 10, 2025, 14:00 PM -
Prenatal Exposure to Antiseizure Medication and Risk of Adverse Obstetrical Outcomes: A Population-Based Study
Mar 10, 2025, 14:00 PM